Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

PsyMINT: Mobile Health (mHealth) Intervention to Support Self-Management of Pain and Symptoms for Cancer Survivors

NCT ID: NCT07332377Sponsor: Virginia Commonwealth UniversityLast updated: 2026-03-18

Summary

This is a feasibility pilot test of a single-arm intervention to evaluate the beta version of an mHealth app-based behavioral intervention prior to scaling for a randomized controlled trial (RCT). This mHealth intervention is designed to enhance self-efficacy and support pain and symptom self-management among post-treatment cancer survivors.

Detailed description

The intervention involves a set of tested intervention messages, ecological momentary assessments (EMAs), and e-diary entries to our PsyMINT mobile app. A 1-week mHealth intervention to cancer survivors who experience pain will be delivered. The feasibility of an mHealth app platform (PsyMINT) as a message presentation environment will be delivered and evaluated. The app messages will target five topics/modules, including psychoeducational materials related to pain management; positive psychology; opioid literacy; skill building for patient-provider communication and trust; and quality of life.

Arms & interventions

  • BehavioralMobile Health (mHealth) Intervention

    Individuals will use the mHealth app for 1 week. Participants will interact with evidence-based messages and will complete ecological momentary assessments (EMA's) (two times per day) and electronic diaries (e-diaries) daily.

Outcome measures

Primary

  • Feasibility and acceptability of the mobile health (mHealth) intervention

    The feasibility and acceptability of the behavioral intervention will be assessed using a pre-validated measure, the 19-item Post-Study System Usability Questionnaire (PSSUQ)87 (e.g., "It was simple to use this app") on a 7-point Likert scale. Acceptability and feasibility outcomes will be evaluated through analysis of mean scores and proportions, including: * Proportion of participants retained, * Proportion who complete at least 80% of EMAs, * 19-item Post-Study System Usability Questionnaire (PSSUQ) mean scores to be greater than 5 (as indicators of feasibility and acceptability).

    Time frame: Baseline and end of one week intervention

Secondary

  • Self-efficacy for pain management

    Time frame: Baseline and end of one week intervention

  • Improved quality of life using a brief version of the Functional Assessment of Cancer Therapy (FACT-G)

    Time frame: Baseline and end of one week intervention

  • Improved Quality of Life using the European Organization for Research and Treatment of Cancer (EORTC)'s Quality of Life Questionnaire (QLQ-C30)

    Time frame: Baseline and end of one week intervention

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * In a post-treatment stage with no evidence of disease (complete remission) * Diagnosed with cancer in the past three years * Experiencing cancer/treatment-related pain * ≥ 18 years of age at the time of first diagnosis * Cognitively able to actively participate in an online-based study * Able to read, write, and understand English Exclusion Criteria: * Individuals who currently use any medication for psychiatric reasons (including stimulants, and mood stabilizers) * Patients with major psychotic disorders (bipolar disorder or schizophrenia) and/or substance use disorders. * Those who are currently pregnant or plan to become pregnant in the next three months

Study locations (1)

Virginia Commonwealth University

Richmond, Virginia, 23298

Recruiting
Sun Jung Kim, Ph.D · Contact
804-628-4688sjkim2@vcu.edu
Sun Jung Kim, Ph.D · Principal Investigator